Mellgren Gunnar, Holm Pål Ivar, Lien Ernst Asbjørn, Bleskestad Inger H, Aanderud Sylvi, Bindoff Laurence
Hormonlaboratoriet, Haukeland Sykehus 5021 Bergen.
Tidsskr Nor Laegeforen. 2002 Apr 20;122(10):1029-31.
Thyrotoxic periodic paralysis (TPP) is a complication of hyperthyroidism.
We describe two patients with TPP.
A 26-year-old man from Vietnam had weight loss, tachycardia, palpitations and heat intolerance for five months. Episodic leg and arm weakness developed three months after debut of symptoms. The second patient, a 23-year old woman from the Philippines, had had episodic leg weakness in the evenings after dinner for three weeks. Her attacks resolved spontaneously overnight. Physical examination of both patients revealed tachycardia and symmetrical proximal weakness involving both arms and legs. ECG and electrolyte analysis indicated a severe hypokalaemia; thyroid function tests showed hyperthyroidism. Both patients were diagnosed as having Graves' thyrotoxicosis and TPP. They were initially treated with propranolol and subsequently with carbimazole. The first patient had recurrence of thyrotoxicosis and paralysis after 16 months, whereas the second patient has remained symptom-free.
TPP is most common in Asian males, very few cases are reported in females. In Western countries TPP is rare, but with increasing immigration, TPP is likely to occur more frequently.
甲状腺毒症性周期性瘫痪(TPP)是甲状腺功能亢进的一种并发症。
我们描述了两名TPP患者。
一名来自越南的26岁男性,出现体重减轻、心动过速、心悸和不耐热症状达五个月。症状出现三个月后,出现发作性腿部和手臂无力。第二名患者是一名来自菲律宾的23岁女性,晚餐后晚上出现发作性腿部无力,持续三周。她的发作在一夜之间自行缓解。对两名患者的体格检查均显示心动过速和累及双臂和双腿的对称性近端无力。心电图和电解质分析表明严重低钾血症;甲状腺功能检查显示甲状腺功能亢进。两名患者均被诊断为格雷夫斯甲状腺毒症和TPP。他们最初接受普萘洛尔治疗,随后接受卡比马唑治疗。第一名患者在16个月后出现甲状腺毒症和瘫痪复发,而第二名患者一直无症状。
TPP在亚洲男性中最为常见,女性病例报道极少。在西方国家,TPP很少见,但随着移民增加,TPP可能会更频繁地发生。